Advanced Deep Learning for Accelerated Drug Discovery: Approaches, Challenges, and Future Expectations

Advanced models of deep learning have been transformational tools for discovering drugs and solving problems related to cost, time, and complexity. Using complex network frameworks such as recurrent neural networks (RNNs), convolutional neural networks (CNNs), generative adversarial networks (GANs), and graph neural networks (GNNs), researchers have made major improvements in predicting drug-target interactions, performing virtual screens, and developing novel drugs. Those frameworks effectively occupy elaborate biochemical relations and precisely imitate complicated molecular reciprocities. Nevertheless, significant issues remain, like data shortages arising from restricted access to (high-quality) datasets, model predictions' interpretability, and the scalability to include considerable and assorted datasets. To efficiently address these issues, innovative strategies, including diverse techniques of data augmentation, like molecular graph transformations, have been applied to improve datasets. Reinforcement learning has helped improve molecular structures to accomplish desired characteristics, while ‎ensemble learning, which integrates various model structures, has proven effective in improving prediction ‎reliability. Incorporating multi-modal datasets, like pharmacophores properties, 3D molecular ‎representations, and molecular graphs, increases the accuracy of prediction by occupying spatial and ‎even functional molecular properties. Despite these advances, issues remain in multi-drug modeling, drug resistance management, and accurate toxicity prediction. Future works focus on the importance of explainable AI in strengthening model interpretability, with hybrid structures that incorporate machine learning and experimental feedback to simplify the therapeutic scheme. By addressing these challenges and adopting innovative approaches, deep learning is set to revolutionize drug discovery, enabling a more efficient, accurate, and reliable development pipeline for novel therapeutics. This study highlights how model interpretability and confidence can be enhanced by integrating multigene data and leveraging explainable AI techniques. By focusing on these cutting-edge developments, this study aims to provide practical insights for researchers and practitioners to accelerate the development of safe, effective, and personalized therapeutics